StockData

Alcon vs STAAR Surgical

ALC and STAA side by side, both in measuring, analyzing, and controlling instruments; photographic, medical and optical goods; watches and clocks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ALC and STAA compare

STAAR Surgical grew revenue faster over the last twelve months (51.3% versus 4.9% for Alcon).

Alcon keeps more of each dollar of sales as profit, with a net margin of 9.4% compared with 1.1% at STAAR Surgical.

STAAR Surgical scores higher on the StockData Score (10 against 7 for Alcon), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricALCSTAA
Size and price
Market cap–$1.2B
Share price$71.45$24.54
Change, 1 year−2.9%−7.7%
Change, 5 years−16.5%−78.8%
Beta (5Y)0.841.50
Employees25K957
StockData Score
Total score710 (better)
Valuation score00
Growth score12 (better)
Performance score22
Health score46 (better)
Dividend score00
Valuation
P/E–351×
P/S–3.6×
P/B–3.4×
EV/EBITDA–76.4×
FCF yield–−0.55%
Fair value–$15.38
Margin of safety–−59.6%
Growth
Revenue growth (TTM)4.9%51.3% (better)
Revenue growth, 5Y average8.8% (better)7.9%
Net income growth (TTM)−3.7%–
EPS growth (TTM)−3.4%–
Profitability
Gross margin55.2%76.6% (better)
Operating margin13.1% (better)4.0%
Net margin9.4% (better)1.1%
FCF margin16.6% (better)−2.0%
Return on equity4.5% (better)1.1%
Return on invested capital4.6% (better)4.2%
Financial health
Debt / equity0.22 (better)0.00
Net debt / EBITDA2.47–
Interest coverage6.7×–
Current ratio2.094.66 (better)
Altman Z-score–7.82
Piotroski F-score6 (better)2
Dividends and buybacks
Payout ratio16.9%–
Shareholder yield–0.00%
Ownership
Held by institutions–110%
Held by insiders0.00%–
Insider net buying, 12 months–$62.8M
Short interest, % of float3.7%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.